Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.6341
+0.0532 (9.16%)
At close: Sep 17, 2026, 4:00 PM EDT
0.6003
-0.0338 (-5.33%)
After-hours: Sep 17, 2026, 5:59 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $21.1 million as of September 17, 2026. Its market cap has decreased by -46.58% in one year.
Market Cap
21.10M
Enterprise Value
n/a
1-Year Change
-46.58%
Ranking
Category
Stock Price
$0.63
ChartMarket Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $21.10M, a decrease of -82.81%. That is a compound annual growth rate of -23.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 21.10M | -58.80% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 22.54M |
| Palatin Technologies | 22.42M |
| PDS Biotechnology | 22.34M |
| Longeveron | 22.06M |
| Lantern Pharma | 21.86M |
| Cellectar Biosciences | 21.83M |
| Akari Therapeutics, | 21.49M |
| GridAI Technologies | 21.03M |